Navigation Links
deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Date:10/11/2007

REYKJAVIK, Iceland, Oct. 11 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODE MI(TM), a reference laboratory test for variations in the genome (called SNPs) that the company has associated with increased risk of myocardial infarction, or heart attack. The SNPs are located on chromosome 9 and were discovered by deCODE earlier this year. As described in the journal Science in July, deCODE scientists found that people who carry two copies of these variants are at double the risk of suffering an early heart attack -- before the age of 50 in men and 60 in women -- than are those who do not carry them. deCODE validated the role of these variants in five groups of patients and controls from Iceland and the United States, and other researchers have replicated this finding in several European, US, and Canadian cohorts.

"With the launch of deCODE MI, we have taken another of our breakthroughs in genetics and transformed it into a new tool in the fight to prevent heart attack. While many risk factors for heart attack are understood, the disease remains the leading cause of death in the industrialized world and the early- onset cases often take both patients and doctors so dangerously by surprise. deCODE MI(TM) tests for a genetic risk factor that is independent of other risks such as cholesterol, obesity and smoking, and therefore provides a means of identifying individuals who may derive particular benefit from earlier and more aggressive prevention efforts," said Dr. Kari Stefansson, CEO of deCODE.

How to order deCODE MI(TM)

deCODE MI(TM) is performed in deCODE's Clinical Laboratory Improvement Amendments (CLIA) certified laboratory, and must be authorized by a qual
'/>"/>

SOURCE deCODE genetics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
5. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
6. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
7. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
8. Major Manufacturer of Unapproved and Adulterated Drugs
9. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
10. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
11. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or the ... $125 million aggregate principal amount of 3.75% Convertible Senior ... and sold only to qualified institutional buyers pursuant to ... amended (the "Securities Act"). The Notes bear ... payable semiannually in arrears on June 15 and December ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, ... (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), ... for clinical trials announce that they have formed ... Services (i-CTMS). i-CTMS will provide a broad range ... biotechnology and medical device companies. i-CTMS ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... COLUMBUS, Ohio, Jan. 8 IntelligentMDx a developer and ... that verification studies of the IntelligentMDx BK Viral ... the Limit of Detection, linearity, specificity and reproducibility ... were determined. The data obtain agreed with internally ...
... have identified mutations in a gene that predict a high ... Although the researchers caution that further research is needed to ... or IKAROS, lead to leukemia relapse, the findings ... to assess the risk of treatment failure. By using a ...
Cached Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6
(Date:12/19/2014)... 2014 (HealthDay News) -- Traveling through the same U.S. ... to three others within a four-hour time span, illustrating ... report shows. "The exposures in this report were ... an international terminal, highlighting the fact that measles is ... an infectious disease specialist at the U.S. Centers for ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 While countless companies ... do not realize the potential dangers of their purchase. Not ... prescription from a qualified doctor, but patients who buy hCG ... point that there is actually no real hCG present. Illegal ... where there are no safety standards and may contain unknown ...
(Date:12/17/2014)... Providence, RI (PRWEB) December 17, 2014 ... nationally recognize private practices that have made outstanding ... and in support and progression of private practice ... the American Physical Therapy Association. , On behalf ... DPT, OCS, owner and CEO of Performance accepted ...
(Date:12/17/2014)... WI (PRWEB) December 17, 2014 In ... Administrators and its Argus Claim Review division have ... of the most common ways savings are achieved on ... (TPA) attributes millions of dollars in savings to Argus ... in 2013. , As explained by Tom Doney, Cypress ...
(Date:12/17/2014)... Project Veritas is releasing a video ... MIT economist and Obamacare architect Jonathan Gruber to public ... the interview, which is being distributed on YouTube. , ... mislabeling in the Affordable Care Act in order to ... billion dollar per year tax grab. , “President Obama ...
Breaking Medicine News(10 mins):Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
... Yosef Shiloh, Ph.D., a David and Inez Myers professor ... genetics and biochemistry in the Sackler School of Medicine ... Annual AACR G.H.A. Clowes Memorial Award for his studies ... genomic instability syndrome ataxia-telangiectasia (A-T). "Dr. Shiloh is ...
... that a novel form of personalized therapy that ... to fight tumors could treat metastatic melanoma and ... therapeutic approach against these and other cancers. ... body,s immune system to fight cancer. Immune cells, ...
... , MONDAY, Jan. 31 (HealthDay News) -- Two new studies ... cancer: melanoma, a deadly malignancy that first appears in the ... The first study, appearing in the Jan. 31 issue ... engineered immune cells from the patient to fight off the ...
... , MONDAY, Jan. 31 (HealthDay News) -- Daytime ... improves greatly after surgery for the disorder, according to a ... partially or completely blocked in short spurts, causing pauses in ... occur 30 times or more an hour, disrupting sleep. The ...
... stem cells in the gut relieves a potentially lethal complication ... published online on January 31 in the Journal of ... can cure diseases such as leukemia but it can also ... (GVHD). A group led by Takanori Teshima at Kyushu ...
... American Chemical Society (ACS) today launched the inaugural edition of ... online snapshot of the countless ways in which chemistry improves ... special video welcome from Nancy B. Jackson, Ph.D., who serves ... Sandia National Laboratories in New Mexico. Every month through ...
Cached Medicine News:Health News:Yosef Shiloh, Ph.D., receives the 51st Annual AACR G.H.A. Clowes Memorial Award 2Health News:Yosef Shiloh, Ph.D., receives the 51st Annual AACR G.H.A. Clowes Memorial Award 3Health News:Novel immune system-based gene therapy induces strong responses in metastatic melanoma, sarcoma 2Health News:New Therapies Offer Insight Into Battling Deadly Melanomas 2Health News:New Therapies Offer Insight Into Battling Deadly Melanomas 3Health News:Drowsiness May Decline After Apnea Surgery 2Health News:American Chemical Society unveils International Year of Chemistry virtual journal 2Health News:American Chemical Society unveils International Year of Chemistry virtual journal 3
... VISION is Guidant's first cobalt chromium stent ... MINI VISION to have remarkably thin struts ... creating a highly deliverable stent. Less metal, ... outcomes in small vessel treatment. The Guidant ...
... IRIS Medical IQ 810 infrared diode ... retinal disorders and glaucoma. The Companys ... technological innovation and is designed to ... (MIP) procedures in the office and ...
... early is best corrected with GP lenses. ... be present, GP lenses will help the ... will neutralize the distortions of the corneal ... is a fitting challenge for even the ...
... "a quantum leap forward in the evolution of ... Rose K lens has become the world's most ... keratoconus.,Unlike traditional contact lenses, the complex geometry built ... the cone like shape of the cornea, for ...
Medicine Products: